We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
-3.08%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$584M
AUM Growth
-$30.8M
(-5%)
Cap. Flow
-$1.84M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
24.56%
Holding
490
New
13
Increased
6
Reduced
11
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$695K |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$627K |
| 3 |
Sanofi
SNY
|
+$579K |
| 4 |
ExxonMobil
XOM
|
+$566K |
| 5 |
VERV
Verve Therapeutics
VERV
|
+$447K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$1.44M |
| 2 |
COHR
Coherent Inc
COHR
|
+$1.33M |
| 3 |
Chevron
CVX
|
+$549K |
| 4 |
T-Mobile US
TMUS
|
+$548K |
| 5 |
Lowe's Companies
LOW
|
+$545K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.39% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 11.84% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUD
476
DELISTED
Audacy, Inc.
AUD
| $6K | ﹤0.01% |
16,000
| – | – |
|
|
LCI
477
DELISTED
Lannett Company, Inc.
LCI
| $5K | ﹤0.01% |
2,500
| – | – |
|
478
Blackbaud
BLKB
$2.08B
| – | – |
-4,000
| Closed | -$232K |
|
479
Kohl's
KSS
$2.19B
| – | – |
-7,500
| Closed | -$268K |
|
480
ManpowerGroup
MAN
$2.63B
| – | – |
-3,000
| Closed | -$229K |
|
481
Mativ Holdings
MATV
$711M
| – | – |
-9,000
| Closed | -$226K |
|
482
Organon & Co
OGN
$3.57B
| – | – |
-8,025
| Closed | -$271K |
|
483
Universal Health Services
UHS
$10.5B
| – | – |
-2,000
| Closed | -$201K |
|
484
Ventas
VTR
$47.9B
| – | – |
-3,933
| Closed | -$202K |
|
485
Dentsply Sirona
XRAY
$2.43B
| – | – |
-6,000
| Closed | -$214K |
|
|
INVX
486
Innovex International
INVX
$1.97B
| – | – |
-8,000
| Closed | -$206K |
|
|
JBTM
487
JBT Marel
JBTM
$6.39B
| – | – |
-2,160
| Closed | -$239K |
|
|
CTEK
488
DELISTED
CynergisTek, Inc.
CTEK
| – | – |
-86,000
| Closed | -$103K |
|
|
COHR
489
DELISTED
Coherent Inc
COHR
| – | – |
-5,000
| Closed | -$1.33M |
|
|
HR
490
DELISTED
Healthcare Realty Trust Incorporated
HR
| – | – |
-7,800
| Closed | -$212K |
|
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q3 2022 Portfolio in Review
As of Q3 2022, NJ State Employees Deferred Compensation Plan held 490 positions worth $584M, down 5% from $614M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
NJ State Employees Deferred Compensation Plan's Q3 2022 filing shows 13 new, 6 increased, 11 reduced and 13 closed positions. Its largest new stake was Sarepta Therapeutics: 6,900 shares worth $763K. The largest sale was Union Pacific, an estimated $1.44M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- NJ State Employees Deferred Compensation Plan's largest Q3 2022 buy was Sarepta Therapeutics: 6,900 shares worth $763K.
- NJ State Employees Deferred Compensation Plan added most to ExxonMobil in Q3 2022, an estimated $566K increase.
- NJ State Employees Deferred Compensation Plan's biggest Q3 2022 reduction was Union Pacific, cutting an estimated $1.44M.
- NJ State Employees Deferred Compensation Plan fully exited Coherent Inc in Q3 2022, selling an estimated $1.33M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $584M portfolio in Q3 2022.
- NJ State Employees Deferred Compensation Plan opened 13 new positions and closed 13 in Q3 2022.
- NJ State Employees Deferred Compensation Plan's portfolio value fell 5% quarter-over-quarter to $584M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2022, filed 28 Oct 2022.